University of Nebraska Medical Center Led Study Published in Major Journal About Potential New HIV Treatment
March 06, 2020
March 06, 2020
OMAHA, Nebraska, March 6 -- The University of Nebraska Medical Center issued the following news release:
This year, people living with HIV expect to have another option when it comes to treating their disease.
A twice a month injection regimen using cabotegravir and rilpivirine was found as effective as the standard treatment of a daily oral three-drug regimen for people with human immunodeficiency virus type-1 (HIV-1). The results came from two studies -- Antiretrovira . . .
This year, people living with HIV expect to have another option when it comes to treating their disease.
A twice a month injection regimen using cabotegravir and rilpivirine was found as effective as the standard treatment of a daily oral three-drug regimen for people with human immunodeficiency virus type-1 (HIV-1). The results came from two studies -- Antiretrovira . . .